Sign In
Markets
Very little value in most parts of market after recent run-up in mega-cap names, says brokerage
Pharma
Pharma firms valuations do not factor in threats from acceleration in generics adoption in India
FIIs up stake in Patanjali, other stocks in Q2
2-wheeler listed cos remain expensive
Despite flat top line, BSE-500 cos see rise in net
Industry
Valuations of two wheeler listed companies remain expensive, says brokerage
PSU stocks soar high after BJP’s victory in 3 States
BSE 500 companies revenues flat but profits zoom
Liquidation remains most common path of closure for cases under insolvency resolution process.
Mega-cap stocks lag in returns
Mounting pressure on banks’ top line
Lower non-oil imports lead to narrowing of goods trade deficit
